Harmony Biosciences Holdings, Inc. Profile Avatar - Palmy Investing

Harmony Biosciences Holdings, Inc.

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive day…
Biotechnology
US, Plymouth Meeting [HQ]

Filings / Resources

Link Index · Filing Reader · 10K/10Q
Loading may take some time.
SEC
Could not find a filing
Transcripts

Gather insights into the latest earnings call through our transcripts.

End of HRMY's Analysis
CIK: 1802665 CUSIP: 413197104 ISIN: US4131971040 LEI: - UEI: -
Secondary Listings
HRMY has no secondary listings inside our databases.